Matteo Trotta
EVP, GM, Dermatology US · INCYTE CORP
Individual
- 2025
- Mar 26, 2026
- 3
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Matteo Trotta files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Herve Hoppenot - $19.77M in INCY purchases and sales in the last 12 months
- Pablo J. Cagnoni - $14.10M in INCY purchases and sales in the last 12 months
- Steven H. Stein - $6.27M in INCY purchases and sales in the last 12 months
- Patrick A. Mayes - $6.01M in INCY purchases and sales in the last 12 months
- Paul J. Clancy - $1.42M in INCY purchases and sales in the last 12 months
- Thomas Tray - $543K in INCY purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Matteo Trotta?
Matteo Trotta is a corporate insider, tracked as EVP, GM, Dermatology US of INCYTE CORP (INCY). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Matteo Trotta last file a Form 4?
The most recent primary Form 4 on record is dated 26 March 2026, one of 3 filings going back to 2025.
